Navigation Links
Metabolix Executives to Present at Leading Industry Conferences
Date:6/10/2013

CAMBRIDGE, Mass., June 10, 2013 /PRNewswire/ -- Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven bioscience company focused on delivering sustainable solutions for plastics, chemicals and energy, today announced that its executives will be presenting at two leading industry conferences in June. Metabolix President and Chief Executive Officer Richard P. Eno will discuss trends in the biopolymers industry at Smithers Rapra's Biopolymers Symposium 2013 on June 11, and he will moderate a panel at the Biotechnology Industry Organization's (BIO) 10th Annual World Congress on Industrial Biotechnology on June 19. In addition, Max Senechal, Metabolix's vice president of biobased chemicals, will discuss commercialization strategies for renewable chemicals at BIO World Congress on June 17.

(Logo: http://photos.prnewswire.com/prnh/20130607/NE28327LOGO-b)

At the Biopolymers Symposium, Mr. Eno will participate in a panel discussion with executives from NatureWorks and Virent. The session will focus on the future of biopolymers, and Mr. Eno will address Metabolix's experience working with customers to achieve commercial success.

At the BIO World Congress on Industrial Biotechnology, Mr. Senechal will participate in the "Renewable Chemicals through Strain Engineering and Process Optimization" panel discussion. Executives and researchers from Green Biologics, zuChem, PRAJ-Matrix and the University of Illinois will also be part of the session. Separately, Mr. Eno will be moderating the "Biomanufacturing at Commercial Scale" panel discussion on commercializing renewable chemicals with executives from Genomatica, Myriant, Clariant and Ajinomoto. Smithers Rapra's Biopolymers Symposium 2013What:"The Future of Biopolymers" panel discussionWho:Richard Eno, president and CEO, MetabolixWhen:Tuesday, June 11, 2013 from 8:40-9:40 a.m. Where: The Field Museum1400 S Lake Shore DriveChicago, IL, 60605 BIO's 10th Annual World Congress on Industrial BiotechnologyWhat:"Renewable Chemicals through Strain Engineering and Process Optimization" and "Biomanufacturing at Commercial Scale" panel discussionsWho:Max Senechal, vice president of biobased chemicals, and Richard Eno, president and CEO, MetabolixWhen:Monday, June 17 from 8:30-10 a.m. (Senechal) and Wednesday, June 19 from 8-10 a.m. (Eno)Where: Palais des congres de Montreal159 Saint-Antoine West, 9th floorMontreal (Quebec) H2Z 1H2, CanadaAbout Metabolix Metabolix, Inc. is an innovation-driven bioscience company delivering sustainable solutions to the plastics, chemicals and energy industries. Metabolix is developing and commercializing a family of high-performance biopolymers targeted to the markets for film and bag applications, performance additives and functional biodegradation. Metabolix's biobased chemicals platform utilizes its novel "FAST" recovery process to enable the production of cost-effective, alternative replacements for petroleum-based industrial chemicals. Metabolix is also developing a platform for co-producing plastics, chemicals and energy from crops. Metabolix has established an industry-leading intellectual property portfolio that, together with its knowledge of advanced industrial practice, provides a foundation for industry collaborations.

For more information, please visit www.metabolix.com. (MBLX-G)

 


'/>"/>
SOURCE Metabolix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
2. GDS International Confirms the Attendance of Top Executives to its Eleventh North American Healthcare Summit in December
3. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
4. OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)
5. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
6. Industry Executives to Explore the Future of Life Sciences Research Powered By Big Data Analytics
7. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
8. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
9. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
10. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
11. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , April 29, 2016 ... by Transparency Market Research "Separation Systems for Commercial ... Growth, Trends, and Forecast 2015 - 2023", the ... at US$ 10,665.5 Mn in 2014 and is ... from 2015 to 2023 to reach US$ 19,227.8 ...
(Date:4/29/2016)... Italy , April 29, 2016 ... 5.11, the latest update to its industry-leading treatment planning ... shown that Monaco version 5.11 ... can now attain calculation speeds up to four times ... . With the industry,s gold standard ...
(Date:4/28/2016)... Boston, MA (PRWEB) , ... April 28, 2016 ... ... (EDT), Asymmetrex will deliver a talk on its first-in-class technologies for ... the 2016 Meeting on RNAiMicroRNA Biology to Reprogramming & CRISPR-based Genome ...
(Date:4/27/2016)... ... April 27, 2016 , ... Shimadzu ... at the Spring 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance instruments enable ... metals, and more. Expo attendees can stop by booth 1021 to learn how ...
Breaking Biology Technology:
(Date:3/11/2016)... -- http://www.apimages.com ) - --> http://www.apimages.com ) ... AP Images ( http://www.apimages.com ) - Germany ... the new refugee identity cards. DERMALOG will be unveiling this device, ... Hanover next week.   --> Germany ... produce the new refugee identity cards. DERMALOG will be unveiling this ...
(Date:3/9/2016)... , March 9, 2016 ... government identified that more than 23,000 public service employees ... had been receiving their salary unlawfully.    --> ... country,s government identified that more than 23,000 public service ... or had been receiving their salary unlawfully.    ...
(Date:3/3/2016)... DE SOTO, Kansas , March 3, 2016 /PRNewswire/ ... offer Oncimmune,s Early CDT®-Lung, a blood test to ... lung cancer Early CDT®-Lung test to its ... --> Early CDT®-Lung test to its clients which ... Oncimmune, a leader in early cancer detection, today announced ...
Breaking Biology News(10 mins):